EBIC Website Search
- There are no results for your query, try again.
The EBIC Executive Committee signed an agreement with NeuroVive Pharmaceuticals AB to collaborate with regard to the organisation and conduct of an european multicenter clinical trial on NeuroSTAT©. The active ingredient of NeuroSTAT© is cyclosporine-A which is considered a promising neuroprotective agent with a number of putative mechanisms, including mitocondrial protection.